predicted: 26kDA; observed: 33kDa Antibodies

predicted: 26kDA; observed: 33kDa

PARTNERSHIP OPPORTUNITIES

NeoBiotechnologies holds Exclusive rights to 10,000 recombinant and hybridoma antibody products, available for Licensing or Collaboration.

LETS TALK